Production (Stage)
Pangenomic Health Inc.
NARA
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.89M | -2.77M | -2.57M | -2.72M | -1.58M |
| Total Depreciation and Amortization | 4.00K | 6.20K | 8.40K | 9.20K | 9.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.88M | 1.82M | 1.78M | 1.78M | 173.10K |
| Change in Net Operating Assets | 917.00K | 898.30K | 507.50K | 567.40K | 803.60K |
| Cash from Operations | -83.50K | -41.80K | -271.40K | -367.60K | -596.90K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 47.00K | 47.00K | 385.00K | 511.40K | 814.40K |
| Total Debt Repaid | -- | -- | 110.90K | 110.90K | 110.90K |
| Issuance of Common Stock | -- | -- | -- | -- | 900.00 |
| Repurchase of Common Stock | -- | -- | -107.70K | -108.60K | -108.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.30K | 0.00 | -1.70K | -800.00 | 0.00 |
| Cash from Financing | 65.20K | 34.30K | 283.90K | 378.10K | 605.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.30K | -7.50K | 12.50K | 10.50K | 8.70K |